DHEA(S)--a novel marker in Cushing's disease

Standard

DHEA(S)--a novel marker in Cushing's disease. / Burkhardt, T; Schmidt, N O; Vettorazzi, E; Aberle, J; Mengel, M; Flitsch, J.

In: ACTA NEUROCHIR, Vol. 155, No. 3, 01.03.2013, p. 479-84; discussion 484.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Burkhardt, T, Schmidt, NO, Vettorazzi, E, Aberle, J, Mengel, M & Flitsch, J 2013, 'DHEA(S)--a novel marker in Cushing's disease', ACTA NEUROCHIR, vol. 155, no. 3, pp. 479-84; discussion 484. https://doi.org/10.1007/s00701-012-1596-6

APA

Burkhardt, T., Schmidt, N. O., Vettorazzi, E., Aberle, J., Mengel, M., & Flitsch, J. (2013). DHEA(S)--a novel marker in Cushing's disease. ACTA NEUROCHIR, 155(3), 479-84; discussion 484. https://doi.org/10.1007/s00701-012-1596-6

Vancouver

Burkhardt T, Schmidt NO, Vettorazzi E, Aberle J, Mengel M, Flitsch J. DHEA(S)--a novel marker in Cushing's disease. ACTA NEUROCHIR. 2013 Mar 1;155(3):479-84; discussion 484. https://doi.org/10.1007/s00701-012-1596-6

Bibtex

@article{12a1a588a13b45d58b0fda6355cbeb38,
title = "DHEA(S)--a novel marker in Cushing's disease",
abstract = "INTRODUCTION: Dehydroepiandrosterone sulfate (DHEA(S)) is a multi-functional steroid implicated in a broad range of biological effects, including obesity, diabetes, bone metabolism, neuroprotection, and anti-tumorigenesis. It has not yet undergone wider research in the context of Cushing's disease. The objective of this study was to determine if perioperative blood levels of DHEA(S) correlate with levels of ACTH and cortisol, and therefore may be useful as a new, additional marker for the early definition of cure in patients suffering from Cushing's disease.METHODS: Forty-two consecutive patients undergoing transsphenoidal surgery for Cushing's disease from September 2009 to September 2010 were perioperatively monitored for ACTH, cortisol, and DHEA(S).RESULTS: Pre-operative blood samples revealed ACTH levels of median 65 ng/l (range 11-1,183 ng/l, standard deviation 183.76), cortisol of median 257 μg/l (range 93-803 μg/l, standard deviation 140.88), and DHEA(S) of median 2.22 mg/l (range 0.44-7.79 mg/l, standard deviation 1.82) according to the pathology of Cushing's disease. Postoperative blood samples drawn over a 7-day time span showed a drop in median ACTH to just 14.5 % (median: 9 ng/l, range 2-44, standard deviation 12.75) of its median preoperative figure. Median cortisol levels were reduced to 6.9 % (median: 18 μg/l, range 10-190 μg/l, standard deviation 38.04) of their preoperative values and DHEA(S) levels decreased to 17 % (median: 0.38 mg/l, range 0.05-2.29, standard deviation 0.51). In persistent disease, no patient showed a drop in DHEA(S) below 38 % of its preoperative figures.CONCLUSIONS: DHEA(S) shows the potential to become an additional marker in the diagnosis and follow-up of patients. However, it needs to be examined further, including whether DHEA(S) may also be a useful predictor of recovery of the HPA-axis after successful surgery.",
keywords = "Adenoma, Adolescent, Adrenocorticotropic Hormone, Adult, Aged, Child, Dehydroepiandrosterone Sulfate, Female, Humans, Hydrocortisone, Magnetic Resonance Imaging, Male, Middle Aged, Pituitary ACTH Hypersecretion, Pituitary Neoplasms, Postoperative Complications, Predictive Value of Tests, Reference Values, Tumor Markers, Biological, Young Adult",
author = "T Burkhardt and Schmidt, {N O} and E Vettorazzi and J Aberle and M Mengel and J Flitsch",
year = "2013",
month = mar,
day = "1",
doi = "10.1007/s00701-012-1596-6",
language = "English",
volume = "155",
pages = "479--84; discussion 484",
journal = "ACTA NEUROCHIR",
issn = "0001-6268",
publisher = "Springer Wien",
number = "3",

}

RIS

TY - JOUR

T1 - DHEA(S)--a novel marker in Cushing's disease

AU - Burkhardt, T

AU - Schmidt, N O

AU - Vettorazzi, E

AU - Aberle, J

AU - Mengel, M

AU - Flitsch, J

PY - 2013/3/1

Y1 - 2013/3/1

N2 - INTRODUCTION: Dehydroepiandrosterone sulfate (DHEA(S)) is a multi-functional steroid implicated in a broad range of biological effects, including obesity, diabetes, bone metabolism, neuroprotection, and anti-tumorigenesis. It has not yet undergone wider research in the context of Cushing's disease. The objective of this study was to determine if perioperative blood levels of DHEA(S) correlate with levels of ACTH and cortisol, and therefore may be useful as a new, additional marker for the early definition of cure in patients suffering from Cushing's disease.METHODS: Forty-two consecutive patients undergoing transsphenoidal surgery for Cushing's disease from September 2009 to September 2010 were perioperatively monitored for ACTH, cortisol, and DHEA(S).RESULTS: Pre-operative blood samples revealed ACTH levels of median 65 ng/l (range 11-1,183 ng/l, standard deviation 183.76), cortisol of median 257 μg/l (range 93-803 μg/l, standard deviation 140.88), and DHEA(S) of median 2.22 mg/l (range 0.44-7.79 mg/l, standard deviation 1.82) according to the pathology of Cushing's disease. Postoperative blood samples drawn over a 7-day time span showed a drop in median ACTH to just 14.5 % (median: 9 ng/l, range 2-44, standard deviation 12.75) of its median preoperative figure. Median cortisol levels were reduced to 6.9 % (median: 18 μg/l, range 10-190 μg/l, standard deviation 38.04) of their preoperative values and DHEA(S) levels decreased to 17 % (median: 0.38 mg/l, range 0.05-2.29, standard deviation 0.51). In persistent disease, no patient showed a drop in DHEA(S) below 38 % of its preoperative figures.CONCLUSIONS: DHEA(S) shows the potential to become an additional marker in the diagnosis and follow-up of patients. However, it needs to be examined further, including whether DHEA(S) may also be a useful predictor of recovery of the HPA-axis after successful surgery.

AB - INTRODUCTION: Dehydroepiandrosterone sulfate (DHEA(S)) is a multi-functional steroid implicated in a broad range of biological effects, including obesity, diabetes, bone metabolism, neuroprotection, and anti-tumorigenesis. It has not yet undergone wider research in the context of Cushing's disease. The objective of this study was to determine if perioperative blood levels of DHEA(S) correlate with levels of ACTH and cortisol, and therefore may be useful as a new, additional marker for the early definition of cure in patients suffering from Cushing's disease.METHODS: Forty-two consecutive patients undergoing transsphenoidal surgery for Cushing's disease from September 2009 to September 2010 were perioperatively monitored for ACTH, cortisol, and DHEA(S).RESULTS: Pre-operative blood samples revealed ACTH levels of median 65 ng/l (range 11-1,183 ng/l, standard deviation 183.76), cortisol of median 257 μg/l (range 93-803 μg/l, standard deviation 140.88), and DHEA(S) of median 2.22 mg/l (range 0.44-7.79 mg/l, standard deviation 1.82) according to the pathology of Cushing's disease. Postoperative blood samples drawn over a 7-day time span showed a drop in median ACTH to just 14.5 % (median: 9 ng/l, range 2-44, standard deviation 12.75) of its median preoperative figure. Median cortisol levels were reduced to 6.9 % (median: 18 μg/l, range 10-190 μg/l, standard deviation 38.04) of their preoperative values and DHEA(S) levels decreased to 17 % (median: 0.38 mg/l, range 0.05-2.29, standard deviation 0.51). In persistent disease, no patient showed a drop in DHEA(S) below 38 % of its preoperative figures.CONCLUSIONS: DHEA(S) shows the potential to become an additional marker in the diagnosis and follow-up of patients. However, it needs to be examined further, including whether DHEA(S) may also be a useful predictor of recovery of the HPA-axis after successful surgery.

KW - Adenoma

KW - Adolescent

KW - Adrenocorticotropic Hormone

KW - Adult

KW - Aged

KW - Child

KW - Dehydroepiandrosterone Sulfate

KW - Female

KW - Humans

KW - Hydrocortisone

KW - Magnetic Resonance Imaging

KW - Male

KW - Middle Aged

KW - Pituitary ACTH Hypersecretion

KW - Pituitary Neoplasms

KW - Postoperative Complications

KW - Predictive Value of Tests

KW - Reference Values

KW - Tumor Markers, Biological

KW - Young Adult

U2 - 10.1007/s00701-012-1596-6

DO - 10.1007/s00701-012-1596-6

M3 - SCORING: Journal article

C2 - 23314986

VL - 155

SP - 479-84; discussion 484

JO - ACTA NEUROCHIR

JF - ACTA NEUROCHIR

SN - 0001-6268

IS - 3

ER -